PMID- 26579539 OWN - NLM STAT- MEDLINE DCOM- 20160829 LR - 20181113 IS - 2314-6141 (Electronic) IS - 2314-6133 (Print) VI - 2015 DP - 2015 TI - Computational and Pharmacological Target of Neurovascular Unit for Drug Design and Delivery. PG - 731292 LID - 10.1155/2015/731292 [doi] LID - 731292 AB - The blood-brain barrier (BBB) is a dynamic and highly selective permeable interface between central nervous system (CNS) and periphery that regulates the brain homeostasis. Increasing evidences of neurological disorders and restricted drug delivery process in brain make BBB as special target for further study. At present, neurovascular unit (NVU) is a great interest and highlighted topic of pharmaceutical companies for CNS drug design and delivery approaches. Some recent advancement of pharmacology and computational biology makes it convenient to develop drugs within limited time and affordable cost. In this review, we briefly introduce current understanding of the NVU, including molecular and cellular composition, physiology, and regulatory function. We also discuss the recent technology and interaction of pharmacogenomics and bioinformatics for drug design and step towards personalized medicine. Additionally, we develop gene network due to understand NVU associated transporter proteins interactions that might be effective for understanding aetiology of neurological disorders and new target base protective therapies development and delivery. FAU - Islam, Md Mirazul AU - Islam MM AD - Pharmacogenomics Lab, Department of Pharmacology, University of Malaya, 50603 Kuala Lumpur, Malaysia. FAU - Mohamed, Zahurin AU - Mohamed Z AD - Pharmacogenomics Lab, Department of Pharmacology, University of Malaya, 50603 Kuala Lumpur, Malaysia. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20151022 PL - United States TA - Biomed Res Int JT - BioMed research international JID - 101600173 SB - IM MH - Animals MH - Blood-Brain Barrier/*metabolism MH - Computer Simulation MH - Drug Delivery Systems/*methods MH - *Drug Design MH - Humans MH - *Models, Biological MH - Neurovascular Coupling/drug effects/*physiology MH - *Pharmacokinetics PMC - PMC4633536 EDAT- 2015/11/19 06:00 MHDA- 2016/08/30 06:00 PMCR- 2015/10/22 CRDT- 2015/11/19 06:00 PHST- 2015/08/19 00:00 [received] PHST- 2015/10/04 00:00 [revised] PHST- 2015/10/04 00:00 [accepted] PHST- 2015/11/19 06:00 [entrez] PHST- 2015/11/19 06:00 [pubmed] PHST- 2016/08/30 06:00 [medline] PHST- 2015/10/22 00:00 [pmc-release] AID - 10.1155/2015/731292 [doi] PST - ppublish SO - Biomed Res Int. 2015;2015:731292. doi: 10.1155/2015/731292. Epub 2015 Oct 22.